MedTrace Logo

Percutaneous Tracheostomy With COVID-19

NCT04447638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2020-09-24

No results posted yet for this study

Summary

Coronavirus disease 2019 (COVID-19) has brought about a requirement of intensive care and mechanical ventilation for a significant portion of patients. Percutaneous tracheostomy is performed in order to reduce the complications that may develop due to prolonged endotracheal intubation.

Conditions

  • Tracheostomy

Interventions

PROCEDURE

Tracheostomy with aerosol box in COVID-19 positive patients

Patients who underwent percutaneous tracheostomy with aerosol box in COVID-19 positive patients. The patients age, gender, hospitalization diagnosis, number of intubated days, anesthetic agents used during the procedure, neck ultrasonography data before and during the procedure, and complications were recorded.

Sponsors & Collaborators

  • Çanakkale Onsekiz Mart University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-20
Primary Completion
2020-06-01
Completion
2020-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04447638 on ClinicalTrials.gov